HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$38.39
Day range
$28.10 - $37.12
Year range
$6.78 - $46.80
Market cap
120.95M USD
Avg Volume
444.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.27M | -60.82% |
Operating expense | 4.63M | -28.20% |
Net income | -19.26M | -6.75% |
Net profit margin | -1.52K | -172.47% |
Earnings per share | -3.07 | 70.05% |
EBITDA | -19.88M | -5.96% |
Effective tax rate | -0.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.92M | 6.38% |
Total assets | 88.43M | 3.00% |
Total liabilities | 38.33M | 23.52% |
Total equity | 50.10M | — |
Shares outstanding | 3.59M | — |
Price to book | 2.55 | — |
Return on assets | -51.03% | — |
Return on capital | -73.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.26M | -6.75% |
Cash from operations | -20.10M | 1.16% |
Cash from investing | 10.40M | 115,633.33% |
Cash from financing | -4.00K | 80.95% |
Net change in cash | -9.71M | 52.34% |
Free cash flow | -12.42M | 8.87% |
About
Founded
2018
Headquarters
Website
Employees
68
